NCT06305767 · Interventional trial
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions Bladder Cancer
Delaware Valley sites
- Fox Chase Cancer Center ( Site 0106) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory